Proscia is a digital pathology company founded in 2014, headquartered in Philadelphia. It develops Concentriq, an AI-native platform designed to power pathology workflows for hospitals, clinics, and pharmaceutical companies, supporting cancer discovery, diagnosis, and treatment.
The Concentriq platform powers over 12 million cases annually across more than 4,000 hospitals and clinics worldwide. Its adoption extends to the pharmaceutical industry, with 16 of the top 20 pharmaceutical companies running on the platform.
The company operates at the intersection of artificial intelligence, digital pathology, healthcare, and precision medicine. Its founding conviction centered on the belief that pathology's digital transformation could unlock better patient outcomes and accelerate the development of life-saving therapies.
